Michael Recht
Chief Medical and Scientific Officer, National Hemophilia Foundation, National Hemophilia Foundation · Yale-New Haven Hospital
Credentials: · · · · · · ·
History
Research
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia
New England Journal of Medicine · 2007 · 1,576 citations
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
New England Journal of Medicine · 2014 · 1,036 citations
Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
The EMBO Journal · 1998 · 330 citations
- LV
16 papers
- AS
14 papers
12 papers
12 papers
- CK
11 papers
- RK
11 papers
11 papers
- DD
10 papers
Clinical trials
- 2018–2024
ATHN 7: Hemophilia Natural History Study
Principal investigator · Completed
American Thrombosis and Hemostasis Network